AR061825A1 - Analogos del peptido intestinal vasoactivo (vip) - Google Patents
Analogos del peptido intestinal vasoactivo (vip)Info
- Publication number
- AR061825A1 AR061825A1 ARP070102996A ARP070102996A AR061825A1 AR 061825 A1 AR061825 A1 AR 061825A1 AR P070102996 A ARP070102996 A AR P070102996A AR P070102996 A ARP070102996 A AR P070102996A AR 061825 A1 AR061825 A1 AR 061825A1
- Authority
- AR
- Argentina
- Prior art keywords
- lys
- ala
- thr
- leu
- asn
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Para el tratamiento de las enfermedades obstructivas pulmonares, por ejemplo la EPOC, administrado, por ejemplo, por inhalacion. Reivindicacion 1: Un análogo cíclico del péptido intestinal vasoactivo de formula (1) X-His-R2-Asp-Ala-R5- Phe-Thr-Glu- Asn-Tyr-Thr-Lys-Leu-Arg-Lys-R16-Nle-R18-Ala-Lys-Lys21-Tyr-Leu-Asn-Asp25-Leu-R27-R28-Gly-Gly-Thr-Y [X-(Id. de Sec. N°:2)-Y] en la que X es un H del amino N-terminal de la Histidina que puede estar opcionalmente sustituida por un grupo protector amino hidrolizable, más preferiblemente por un grupo acetilo, Y es el hidroxilo del carboxilo C-terminal de la Treonina que puede estar opcionalmente sustituida por un grupo protector carboxilo hidrolizable, más preferiblemente por NH2, los residuos subrayados indican una union covalente de cadena lateral a cadena lateral del primer aminoácido (Lys21) y el ultimo (Asp25) dentro del segmento, R2 es Ser o Ala, R5 es Thr, Ser, Asp, Gln, Pro o CalfaMeVal, R16 es Gln, Ala o Arg, R18 es Ala, Lys o Glu, R27 es Lys o Leu con la excepcion de que R27 debe ser Lys cuando R5 es CalfaMeVal y R16 es Arg, R28 es Lys o Asn, o una sal farmacéuticamente aceptable de la misma.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81880506P | 2006-07-06 | 2006-07-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR061825A1 true AR061825A1 (es) | 2008-09-24 |
Family
ID=38786842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070102996A AR061825A1 (es) | 2006-07-06 | 2007-07-05 | Analogos del peptido intestinal vasoactivo (vip) |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20080096807A1 (es) |
| EP (1) | EP2041168A2 (es) |
| JP (1) | JP2009542593A (es) |
| KR (1) | KR20090027239A (es) |
| CN (1) | CN101484468A (es) |
| AR (1) | AR061825A1 (es) |
| AU (1) | AU2007271274A1 (es) |
| BR (1) | BRPI0714306A2 (es) |
| CA (1) | CA2656757A1 (es) |
| CL (1) | CL2007001956A1 (es) |
| CR (1) | CR10518A (es) |
| EC (1) | ECSP099029A (es) |
| IL (1) | IL196122A0 (es) |
| MA (1) | MA30590B1 (es) |
| MX (1) | MX2009000013A (es) |
| NO (1) | NO20090027L (es) |
| PE (1) | PE20081000A1 (es) |
| RU (1) | RU2009103811A (es) |
| TW (1) | TW200819139A (es) |
| WO (1) | WO2008003612A2 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2012151296A (ru) | 2010-04-30 | 2014-06-10 | Санва Кагаку Кенкюсо Ко., Лтд | Пептид для улучшения биостабильности биоактивного вещества и биоактивное вещество, имеющее повышенную биостабильность |
| CN102827268B (zh) * | 2011-06-13 | 2016-08-24 | 中肽生化有限公司 | 新型血管肠肽类似物及其制备方法和用途 |
| US8866872B2 (en) | 2011-06-21 | 2014-10-21 | Mitel Networks Corporation | Conferencing and collaboration system and methods thereof |
| US9789164B2 (en) * | 2013-03-15 | 2017-10-17 | Longevity Biotech, Inc. | Peptides comprising non-natural amino acids and methods of making and using the same |
| US11052132B2 (en) * | 2014-05-08 | 2021-07-06 | Phasebio Pharmaceuticals, Inc. | Methods and compositions for treating cystic fibrosis |
| ITUB20159175A1 (it) * | 2015-12-23 | 2017-06-23 | Materie Plastiche Pisane S R L | Composizione polimerica antibatterica |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3879371A (en) * | 1971-09-17 | 1975-04-22 | Sami I Said | Isolation of vasoactive intestinal peptide |
| GB8427651D0 (en) * | 1984-11-01 | 1984-12-05 | Beecham Group Plc | Compounds |
| GB8525852D0 (en) * | 1985-10-19 | 1985-11-20 | Beecham Group Plc | Compounds |
| JPS62246595A (ja) * | 1986-04-17 | 1987-10-27 | Eisai Co Ltd | 気菅支拡張作用・降圧作用ペプタイド |
| US4835252A (en) * | 1987-02-26 | 1989-05-30 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Vasoactive intestinal peptide analogs |
| AU656230B2 (en) * | 1991-10-11 | 1995-01-27 | F. Hoffmann-La Roche Ag | Cyclic vasoactive peptides |
| AU722895B2 (en) * | 1996-02-09 | 2000-08-10 | F. Hoffmann-La Roche Ag | Synthesis of VIP analog |
| US20050203009A1 (en) * | 2004-03-12 | 2005-09-15 | Bayer Pharmaceuticals Corporation | VPAC1 selective antagonists and their pharmacological methods of use |
| WO2006023358A1 (en) * | 2004-08-18 | 2006-03-02 | Eli Lilly And Company | Selective vpac2 receptor peptide agonists |
| MX2007004116A (es) * | 2004-10-08 | 2007-10-05 | Forbes Medi Tech Res Inc | Composiciones farmaceuticas de polipeptidos intestinales vasoactivos. |
-
2007
- 2007-06-26 CN CNA2007800254947A patent/CN101484468A/zh active Pending
- 2007-06-26 MX MX2009000013A patent/MX2009000013A/es not_active Application Discontinuation
- 2007-06-26 KR KR1020097000221A patent/KR20090027239A/ko not_active Application Discontinuation
- 2007-06-26 JP JP2009517165A patent/JP2009542593A/ja active Pending
- 2007-06-26 RU RU2009103811/10A patent/RU2009103811A/ru unknown
- 2007-06-26 CA CA002656757A patent/CA2656757A1/en not_active Abandoned
- 2007-06-26 BR BRPI0714306-0A patent/BRPI0714306A2/pt not_active IP Right Cessation
- 2007-06-26 WO PCT/EP2007/056351 patent/WO2008003612A2/en active Application Filing
- 2007-06-26 EP EP07765625A patent/EP2041168A2/en not_active Withdrawn
- 2007-06-26 AU AU2007271274A patent/AU2007271274A1/en not_active Abandoned
- 2007-07-03 US US11/825,105 patent/US20080096807A1/en not_active Abandoned
- 2007-07-04 TW TW096124342A patent/TW200819139A/zh unknown
- 2007-07-05 CL CL200701956A patent/CL2007001956A1/es unknown
- 2007-07-05 AR ARP070102996A patent/AR061825A1/es unknown
- 2007-07-05 PE PE2007000873A patent/PE20081000A1/es not_active Application Discontinuation
-
2008
- 2008-12-17 CR CR10518A patent/CR10518A/es not_active Application Discontinuation
- 2008-12-22 IL IL196122A patent/IL196122A0/en unknown
-
2009
- 2009-01-05 EC EC2009009029A patent/ECSP099029A/es unknown
- 2009-01-05 NO NO20090027A patent/NO20090027L/no not_active Application Discontinuation
- 2009-01-13 MA MA31568A patent/MA30590B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2041168A2 (en) | 2009-04-01 |
| IL196122A0 (en) | 2011-08-01 |
| AU2007271274A1 (en) | 2008-01-10 |
| PE20081000A1 (es) | 2008-08-06 |
| MX2009000013A (es) | 2009-01-23 |
| CN101484468A (zh) | 2009-07-15 |
| BRPI0714306A2 (pt) | 2014-05-20 |
| NO20090027L (no) | 2009-01-15 |
| KR20090027239A (ko) | 2009-03-16 |
| WO2008003612A3 (en) | 2008-02-28 |
| US20080096807A1 (en) | 2008-04-24 |
| RU2009103811A (ru) | 2010-08-20 |
| MA30590B1 (fr) | 2009-07-01 |
| CA2656757A1 (en) | 2008-01-10 |
| TW200819139A (en) | 2008-05-01 |
| WO2008003612A2 (en) | 2008-01-10 |
| CL2007001956A1 (es) | 2008-04-18 |
| JP2009542593A (ja) | 2009-12-03 |
| ECSP099029A (es) | 2009-02-27 |
| CR10518A (es) | 2009-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI202100085A (es) | Composición farmacéutica para inyección subcutánea que comprende una variante de hialuronidasa humana ph20 y un medicamento | |
| HRP20140616T1 (hr) | Peptidni analog oksintomodulina | |
| JP2012518035A5 (es) | ||
| AR061825A1 (es) | Analogos del peptido intestinal vasoactivo (vip) | |
| KR20190105542A (ko) | 글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체 | |
| RU2011134596A (ru) | Аналоги оксинтомодулина | |
| ES2359850T3 (es) | Péptidos con actividad agonista del receptor del neuropéptido-2 (y2r). | |
| HRP20201353T1 (hr) | Agonisti glukagonskog receptora | |
| AR094181A1 (es) | Agonistas duales de glp1/gip o trigonales de glp1/gip/glucagon | |
| ES2277676T3 (es) | Antagonistas de los peptidos glp-2 intestinotroficos. | |
| PE20130615A1 (es) | Polipeptidos del receptor de activina variante y uso de los mismos | |
| JP2013515057A5 (es) | ||
| US20220111003A1 (en) | Neuroprotective peptides | |
| RU2015101697A (ru) | Аналоги глюкагона, обладающие активностью рецептора gip | |
| RU2010135519A (ru) | Гидрофобные, модифицированные, полученные из pres вируса гепатита в (hbv) пептиды и их использование в качестве ингибиторов проникновения hbv и hdv | |
| JP2019533722A5 (es) | ||
| JP2007204491A (ja) | グルカゴン様ペプチド−２アナログ | |
| JP2017528419A5 (es) | ||
| KR20120137271A (ko) | 신규한 옥신토모듈린 유도체 및 이를 포함하는 비만 치료용 조성물 | |
| EP1789440A4 (en) | REASONS FOR THE FAMILY OF PANCREATIC POLYPEPTIDES AND POLYPEPTIDES CONTAINING THEM | |
| JPH08510205A (ja) | Ｙｙペプチドのアナログとその用途 | |
| DK1877435T3 (da) | Glucagon-lignende peptid 2 (GLP-2)-analoger | |
| JP2014525901A5 (es) | ||
| BRPI1010120A2 (pt) | composição de surfactante reconstituído melhorada contendo análogos de proteína b do surfactante (sp-b) e proteína c do surfactante ( sp-c) | |
| US11103557B2 (en) | Exenatide analogue and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |